Mayo Clinic
The purpose of this study is to provide preliminary evidence for the efficacy of 12 weeks of vagal nerve stimulation (VNS) and nicotine replacement therapy (NRT) for increasing smoking abstinence rates.
This study will evaluate the role of vagal nerve stimulation as a potential adjunct to nicotine patches to help smokers stop smoking.
Inclusion Criteria: * 18 years of age or older at the time of consent. * Currently smoking cigarettes on a regular basis * Motivated to stop smoking (on a scale of 0 to 10, motivation must be 3 or above); * Ability to participate fully in all aspects of the study. * Have the ability to provide informed consent. * Have no contraindicating comorbid health conditions that would interfere with study participation, as determined by the clinical investigators. Exclusion Criteria: * Patients with a current moderate/severe depression as assessed by a score of ≥10 on the Patient Health Questionnaire…
VNS is a handheld, rechargeable, portable device that delivers electrical signals to the vagal nerve when positioned on the skin of the neck at the appropriate location to stimulate the vagal nerve for 2 minutes at each treatment. During these 12 weeks, participants will also use a 21 mg nicotine patch daily.
Use of a 21 mg nicotine patch daily for up to 12 weeks
Arctuva estimate
Verify or correct the compensation shown for this listing.